PMID- 16481105 OWN - NLM STAT- MEDLINE DCOM- 20060630 LR - 20131121 IS - 0304-3940 (Print) IS - 0304-3940 (Linking) VI - 399 IP - 1-2 DP - 2006 May 15 TI - Effects of SDF-1alpha and gp120IIIB on apoptotic pathways in SK-N-SH neuroblastoma cells. PG - 115-20 AB - CXCR4, a chemokine receptor constitutively expressed in the brain, binds both ligands, the chemokine SDF-1alpha and the HIV envelope glycoprotein gp120(IIIB). There seem to be intracellular differences between the neuronal apoptosis induced by SDF-1alpha and that induced by gp120(IIIB), but the apoptotic pathways involved have not been compared in human neuronal cells. In this study, we characterized the apoptotic intracellular pathways activated by neurotoxic concentrations of SDF-1alpha and gp120(IIIB) in human neuroblastoma cells SK-N-SH. SDF-1alpha (10 nM) and gp120(IIIB) (2 nM) induced similar levels of apoptosis after 24 h of incubation (49 +/- 4% and 48 +/- 3%, respectively, of the neurons were apoptotic). SDF1alpha-induced apoptosis was completely abolished by the inhibition of Src phosphorylation by PP2. Exposure to SDF-1alpha (10 nM) triggered an increase in Src phosphorylation, with a maximum after 20 min of incubation (1.80 +/- 0.24 times higher than control, P = 0.01). NMDA calcium flux was enhanced only if cells were incubated with SDF-1alpha for 20 min before applying NMDA. By contrast, gp120(IIIB)-induced apoptosis was not affected by the inhibition of Src phosphorylation. Moreover, gp120(IIIB) enhanced NMDA calcium flux immediately, without modifying Src phosphorylation status. Finally, levels of phospho-JNK increased following exposure to gp120(IIIB) (by a factor of 1.46 +/- 0.4 at 120 min, P = 0.03), but not after exposure to SDF-1alpha. Thus, SDF-1alpha and gp120(IIIB) induced a similar level of neuronal apoptosis, but by activating different intracellular pathways. SDF-1alpha enhanced NMDA activity indirectly via Src phosphorylation, whereas gp120(IIIB) probably activated the NMDA receptor directly and phosphorylated JNK. FAU - Geeraerts, Thomas AU - Geeraerts T AD - Laboratoire Immunologie antivirale systemique et cerebrale, INSERM EMI 0109, Faculte de medecine Paris-Sud, 63 rue Gabriel Peri, 94 276 Le Kremlin Bicetre, France. thgeeraerts@hotmail.com FAU - Deiva, Kumaran AU - Deiva K FAU - M'sika, Ilana AU - M'sika I FAU - Salim, Hassan AU - Salim H FAU - Hery, Christiane AU - Hery C FAU - Tardieu, Marc AU - Tardieu M LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20060214 PL - Ireland TA - Neurosci Lett JT - Neuroscience letters JID - 7600130 RN - 0 (CXCL12 protein, human) RN - 0 (Chemokine CXCL12) RN - 0 (Chemokines, CXC) RN - 0 (HIV Envelope Protein gp120) RN - 0 (Receptors, CXCR4) RN - 0 (Receptors, N-Methyl-D-Aspartate) RN - 6384-92-5 (N-Methylaspartate) RN - EC 2.7.10.2 (src-Family Kinases) RN - EC 2.7.11.24 (JNK Mitogen-Activated Protein Kinases) RN - SY7Q814VUP (Calcium) SB - IM MH - *Apoptosis MH - Calcium/metabolism MH - Cell Line, Tumor MH - Chemokine CXCL12 MH - Chemokines, CXC/*physiology/toxicity MH - HIV Envelope Protein gp120/pharmacology/*physiology MH - Humans MH - In Situ Nick-End Labeling MH - Intracellular Space/metabolism MH - JNK Mitogen-Activated Protein Kinases/metabolism MH - N-Methylaspartate/pharmacology MH - Neuroblastoma MH - Phosphorylation MH - Receptors, CXCR4/biosynthesis MH - Receptors, N-Methyl-D-Aspartate/agonists MH - src-Family Kinases/metabolism EDAT- 2006/02/17 09:00 MHDA- 2006/07/01 09:00 CRDT- 2006/02/17 09:00 PHST- 2005/10/28 00:00 [received] PHST- 2006/01/10 00:00 [revised] PHST- 2006/01/18 00:00 [accepted] PHST- 2006/02/17 09:00 [pubmed] PHST- 2006/07/01 09:00 [medline] PHST- 2006/02/17 09:00 [entrez] AID - S0304-3940(06)00071-1 [pii] AID - 10.1016/j.neulet.2006.01.033 [doi] PST - ppublish SO - Neurosci Lett. 2006 May 15;399(1-2):115-20. doi: 10.1016/j.neulet.2006.01.033. Epub 2006 Feb 14.